Laser irradiation of blood as a method of prevention of oral mucositis

Cover Page

Cite item

Full Text

Abstract

Aim. Study the effectiveness of oral mucositis (OM) prevention by the stimulation of white cells phagocytic activity and activation of endogenous keratinocyte growth factor production by laser blood irradiation method (LBI). Materials and methods. This study covers 44 patients with malignant tumors. 29 patients have already passed the high-dose polychemotherapy complicated by OM development. 15 patients have not passed the high-dose polychemotherapy yet before this admission. In the study we applied the method of identification of the white cells phagocytic activity state using the test sheet of latex microparticles. The study was performed before high-dose polychemotherapy, after LBI and after chemotherapy. Blood exposure to laser irradiation was made by placing the emitter on skin above the large vessels: areas of carotid arteries and veins, cubital, subclavian or popliteal. Results. LBI technique was used in 92 courses of high-dose polychemotherapy. Stimulation of phagocytes by LBI method showed that application of this method before chemotherapy leads to the positive result in all cases. All children (n=44), that were subject to white cells phagocytic activity stimulation, had not OM. Conclusion. Blood test for white cells phagocytic activity gives a chance to determine the actual readiness of the body to resist infections. If it was impossible to predict oral mucositis development before, now implementation of white cells phagocytic activity determination method improves the effectiveness of such prognosis. Thus, first in the world, all results that we obtained became possible only due to implementation of the white cells phagocytic activity test and stimulation of the white cells phagocytic activity and activation of the endogenous keratinocyte growth factor production by laser blood irradiation method.

About the authors

Leonid I Gusev

V.F. Voino-Yasenetski Scientific and Practical Center for Specialized Medical Care for Children

Email: lig46@mail.ru
D. Sci. (Med.) Moscow, Russia

Denis A Pritiko

V.F. Voino-Yasenetski Scientific and Practical Center for Specialized Medical Care for Children

Email: denys.05@mail.ru
Cand. Sci. (Med.) Moscow, Russia

Elena N Lukash

V.F. Voino-Yasenetski Scientific and Practical Center for Specialized Medical Care for Children

laboratory doctor Moscow, Russia

Nadezhda M Ivanova

V.F. Voino-Yasenetski Scientific and Practical Center for Specialized Medical Care for Children

Email: det.onco.ivanova@rambler.ru
D. Sci. (Med.), Full Prof. Moscow, Russia

Elena Y Sergeenko

Pirogov Russian National Research Medical University

Email: elenarsmu@mail.ru
D. Sci. (Med.), Full Prof. Moscow, Russia

References

  1. Dodds M.J. The pathogenesis and characterization of oral mucositis associated with cancer therapy. Oncol Nurs Forum 2004; 31 (Suppl. 4): 5-11.
  2. Bensadoun R.J, Nair R.G. Low-level laser therapy in the prevention and treatment of cancer therapy-induced mucositis: 2012 state of the art based on literature review and meta-analysis. Curr Opin Oncol 2012; 24: 363-70. doi: 10.1097/CCO.0b013e 328352eaa3
  3. Shenep J.L, Kalwinsky D.K, Hutson P.R et al. Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis. J Pediatr 1988; 113 (4): 758-63.
  4. Solomon M.Z, Dokken D.L, Fleischman A.R et al. For IPPC, 2002. The initiative for pediatric palliative care (IPPC): Background and goals. Newton, MA: Education Development Center, Inc. http://www.ippcweb.org/initiative.asp
  5. Rosenthal D.I. Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes. J Support Oncol 2007; 5: 23-31.
  6. Keefe D.M, Peterson D.E, Schubert M.M. Developing evidence based guidelines for the management of alimentary mucositis: process and pitfalls. Support Care Cancer 2006; 14: 492-8.
  7. Keefe D.M, Gibson R.J. Mucosal injury from targeted anti-cancer therapy. Support Care Cancer 2007; 15: 483-90.
  8. Balmant N.V, Reis S.R, Oliveira J.F.P et al. Cancer incidence among adolescents and young adults (15 to 29 years) in Brazil. J Pediatr Hematol Oncol 2016; 38: e88-e96.
  9. Guyatt G.H, Oxman A.D, Kunz R et al. GRADE: going from evidence to recommendations. BMJ 2008; 336: 1049-51. doi: 10.1136/bmj.39493.646875.AE
  10. Düzkaya D.S, Uysal B, Yakut T. The Effect of Oral Care Using an Oral Health Care Guide on Preventing Mucositis in Pediatric Intensive Care. J Pediatr Nurs 2017; 36: 98-102.
  11. Rojas de Morales T, Zambrano O, Rivera L et al. Oral-disease prevention in children with cancer: testing preventive protocol effectiveness. Medicina Oral 2001; 6: 326-34.
  12. Sarzhevsky V.O, Smirnova E.G. Features of pathogenesis, clinical manifestations, prevention and treatment of mucositis in cancer patients. Bulletin of the National medical and surgical Center. N And Pirogov 2012; 7 (3): 123-8.
  13. Raber-Durlacher J.E, von Bultzingslowen I, Logan R.M et al. Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer 2013; 21: 343-55. doi: 10.1007/s00520-012-1594-5
  14. Paris F, Fuks Z, Kang A et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001; 293: 293-7.
  15. Weber J.B, Pinheiro A.L, de Oliveira M.G et al. Laser therapy improves healing of bone defects submitted to autologous bone graft. Photomed Laser Surg 2006; 24: 38-44.
  16. Elad S, Raber-Durlacher J.E, Brennan M.T et al. Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: A position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Support Care Cancer 2015; 23: 223-36.
  17. El Bousaadani A, Eljahd L, Abada R et al. Prevention and treatment of mucositis in children with oral cancers: Practical recommendations. Cancer Radiother 2016; 20 (3): 226-30.
  18. Yu W, Naim J.O, Lanzafame R.J. The effect of laser irradiation on the release of bFGF from 3T3 fibroblasts. Photochem Photobiol 1994; 59: 167-70.
  19. Grossman N, Schneid N, Reuveni H et al. 780 nm low power diode laser irradiation stimulates proliferation of keratinocyte cultures: involvement of reactive oxygen species. Lasers Surg Med 1998; 22: 212-8.
  20. Moore P, Ridgway T.D, Higbee R.G et al. Effect of wavelength on low-intensity laser irradiation-stimulated cell proliferation in vitro. Lasers Surg Med 2005; 36: 8-12.
  21. Agaiby A.D, Ghali L.R, Wilson R, Dyson M. Laser modulation of angiogenic factor production by T-lymphocytes. Lasers Surg Med 2000; 26: 357-63.
  22. Storz P. Mitochondrial ROS-radical detoxification, mediated by protein kinase D. Trends Cell Biol 2007; 17: 13-8.
  23. Кошелев В.Н., Семина Е.А., Камалян А.Б. Сравнительная оценка эффективности применения чрескожного и внутрисосудистого лазерного облучения крови. Матер. Междунар. конф. «Клиническое и экспериментальное применение новых лазерных технологий». Москва-Казань, 1995; с. 395-7.
  24. Блохина Н.П., Ицкович А.И. Изменения функционального состояния полиморфноядерных фагоцитов у новорожденных детей с острыми респираторными заболеваниями под влиянием лазерной терапии. Материалы III Международной конференции: Актуальные вопросы лазерной медицины и операционной эндоскопии. Под редакцией О.К.Скобелкина, А.А.Мартино. Москва-Видное, 1994(б); с. 409-10.
  25. Воронина О.Ю., Каплан М.А., Степанов В.А. Нерезонансный механизм биостимулирующего действия низкоинтенсивного лазерного излучения. Физическая медицина. 1992; 2 (1-2): 40-50.
  26. Гамалея Н.Ф., Стадник В.Я., Рудых З.М. и др. Экспериментальное обоснование и первый опыт применения внутривенного лазерного облучения крови в онкологии. Эксперим. онкология. 1988; 10 (2): 60-3.
  27. Дурнов Л.А., Балакирев С.А., Гусев Л.И. и др. Применение низко-интенсивного лазерного излучения в детской онкологии (экспериментальные и клинические исследования). V1 международная научно-практическая конференция по квантовой медицине. Москва, 6-10 декабря 1999 г.; с. 160-5.
  28. Дурнов Л.А., Гусев Л.И., Балакирев С.А. и др. Низкоинтенсивные лазеры в детской онкологии. Вестн. Российской Академии мед. наук. 2000; 6: 24-7.
  29. Захарченко С.В. Иммуномодулирующий и противорецидивный эффекты магнитоинфракрасной лазерной терапии в комплексном лечении легкой бронхиальной астмы у детей. Автореф. дис. … канд. мед. наук. М., 2005.
  30. Земцев И.З., Лапшин В.П. Механизмы очищения поверхности биомембран от токсических веществ при лазерном облучении крови и других биотканей. Материалы Междунар. конф. «Новые направления лазерной медицины». М., 1996; с. 323-25.
  31. Зырянов Б.Н. Евтушенко В.А, Кицманюк З.Д. Низкоинтенсивная лазерная терапия в онкологии. Томск: STT, 1998.
  32. Karu T. Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J Photochem Photobiol B 1999; 49: 1-17.
  33. Lewis J.C, Maldonado J.E, Mann K.G. Phagocytosis in human platelets: localization of acid phosphatase-positive phagosomes following latex uptake. Blood 1976; 47: 833-40.
  34. Peterson D.E, Barker N.P, Akhmadullina L.I et al. Phase II, randomized, doubleblind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in pa-tients with colorectal cancer who are receiving fluorouracil-based chemotherapy. J Clin Oncol 2009; 27: 4333-8.

Copyright (c) 2019 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies